Contrarily, KLB has also been demonstrated to suppress tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3β/Cyclin D1 signaling pathway 22, 23 and KLB level was significantly decreased and associated with fibrosis stage in liver tissue 24. This evidence concerns the gene KLB and hepatocellular carcinoma.